Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Codiak Biosciences, Inc. (CDAK) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Codiak Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1659352.
Total stock buying since 2020: $20,798,956.
Total stock sales since 2020: $521,696.
Total stock option exercises since 2020: $60,565.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 102,064 | $25,128 | 93,888 | $0 |
| 2022 | 10,940,114 | $7,549,975 | 15,563 | $34,435 | 50,139 | $0 |
| 2021 | 4,761 | $99,981 | 18,409 | $462,133 | 18,409 | $60,565 |
| 2020 | 876,600 | $13,149,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-03 | 0 | $0 | 85,138 | $15,109 | 0 | $0 |
| 2023-02 | 0 | $0 | 16,926 | $10,019 | 93,888 | $0 |
| 2022-09 | 10,933,333 | $7,500,000 | 0 | $0 | 0 | $0 |
| 2022-08 | 0 | $0 | 15,563 | $34,435 | 50,139 | $0 |
| 2022-01 | 6,781 | $49,975 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 2,600 | $54,219 | 2,600 | $8,554 |
| 2021-06 | 0 | $0 | 15,809 | $407,914 | 15,809 | $52,011 |
| 2021-02 | 4,761 | $99,981 | 0 | $0 | 0 | $0 |
| 2020-10 | 876,600 | $13,149,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-30 | Howze Yalonda (See Remarks) | Sale | 1,628 | .20 | 319 |
| 2023-03-29 | Sathyanarayanan Sriram (Chief Scientific Officer) | Sale | 11,762 | .17 | 1,940 |
| 2023-03-29 | Barna Nicole (See Remarks) | Sale | 7,305 | .17 | 1,212 |
| 2023-03-28 | Konstantinov Konstantin (Chief Technology Officer) | Sale | 9,364 | .20 | 1,872 |
| 2023-03-28 | Bain Linda (Chief Financial Officer) | Sale | 13,412 | .17 | 2,266 |
| 2023-03-28 | Williams Douglas E (President & CEO) | Sale | 41,667 | .18 | 7,500 |
| 2023-02-17 | Sathyanarayanan Sriram (Chief Scientific Officer) | Sale | 2,407 | .59 | 1,424 |
| 2023-02-17 | Howze Yalonda (See Remarks) | Sale | 1,603 | .59 | 950 |
| 2023-02-17 | Barna Nicole (See Remarks) | Sale | 1,274 | .59 | 754 |
| 2023-02-17 | Konstantinov Konstantin (Chief Technology Officer) | Sale | 1,391 | .59 | 823 |
| 2023-02-17 | Bain Linda (Chief Financial Officer) | Sale | 2,570 | .59 | 1,521 |
| 2023-02-17 | Williams Douglas E (President & CEO) | Sale | 7,681 | .59 | 4,547 |
| 2023-02-16 | Sathyanarayanan Sriram (Chief Scientific Officer) | Option Ex | 7,350 | .00 | 0 |
| 2023-02-16 | Howze Yalonda (See Remarks) | Option Ex | 4,856 | .00 | 0 |
| 2023-02-16 | Barna Nicole (See Remarks) | Option Ex | 3,150 | .00 | 0 |
| 2023-02-16 | Konstantinov Konstantin (Chief Technology Officer) | Option Ex | 4,200 | .00 | 0 |
| 2023-02-16 | Haddock Jason (Director) | Option Ex | 8,750 | .00 | 0 |
| 2023-02-16 | Bernstein Karen (Director) | Option Ex | 8,750 | .00 | 0 |
| 2023-02-16 | Bain Linda (Chief Financial Officer) | Option Ex | 7,613 | .00 | 0 |
| 2023-02-16 | Gillis Steven (Director) | Option Ex | 8,750 | .00 | 0 |
| 2023-02-16 | Melas Kyriazi Theo (Director) | Option Ex | 8,750 | .00 | 0 |
| 2023-02-16 | Williams Douglas E (President & CEO) | Option Ex | 22,969 | .00 | 0 |
| 2023-02-16 | Cooney Charles L (Director) | Option Ex | 8,750 | .00 | 0 |
| 2022-09-15 | Afeyan Noubar (10% Owner) | Buy | 933,333 | .00 | 0 |
| 2022-09-13 | Arch Venture Partners Viii, L.p. (10% Owner) | Buy | 5,000,000 | 1.50 | 7,500,000 |
| 2022-09-13 | Gillis Steven (Director) | Buy | 5,000,000 | .00 | 0 |
| 2022-08-17 | Sathyanarayanan Sriram (Chief Scientific Officer) | Sale | 2,283 | 2.21 | 5,049 |
| 2022-08-17 | Howze Yalonda (See Remarks) | Sale | 1,512 | 2.21 | 3,347 |
| 2022-08-17 | Barna Nicole (See Remarks) | Sale | 984 | 2.21 | 2,176 |
| 2022-08-17 | Konstantinov Konstantin (Chief Technology Officer) | Sale | 1,308 | 2.21 | 2,894 |
| 2022-08-17 | Bain Linda (Chief Financial Officer) | Sale | 2,364 | 2.21 | 5,231 |
| 2022-08-17 | Williams Douglas E (President & CEO) | Sale | 7,112 | 2.21 | 15,738 |
| 2022-08-16 | Sathyanarayanan Sriram (Chief Scientific Officer) | Option Ex | 7,350 | .00 | 0 |
| 2022-08-16 | Howze Yalonda (See Remarks) | Option Ex | 4,857 | .00 | 0 |
| 2022-08-16 | Barna Nicole (See Remarks) | Option Ex | 3,150 | .00 | 0 |
| 2022-08-16 | Konstantinov Konstantin (Chief Technology Officer) | Option Ex | 4,200 | .00 | 0 |
| 2022-08-16 | Bain Linda (Chief Financial Officer) | Option Ex | 7,613 | .00 | 0 |
| 2022-08-16 | Williams Douglas E (President & CEO) | Option Ex | 22,969 | .00 | 0 |
| 2022-01-20 | Barna Nicole (See Remarks) | Buy | 6,781 | 7.37 | 49,975 |
| 2021-08-09 | Sathyanarayanan Sriram (Chief Scientific Officer) | Sale | 1,300 | 21.55 | 28,013 |
| 2021-08-09 | Sathyanarayanan Sriram (Chief Scientific Officer) | Option Ex | 1,300 | 3.29 | 4,277 |
| 2021-08-06 | Sathyanarayanan Sriram (Chief Scientific Officer) | Sale | 1,300 | 20.16 | 26,206 |
| 2021-08-06 | Sathyanarayanan Sriram (Chief Scientific Officer) | Option Ex | 1,300 | 3.29 | 4,277 |
| 2021-06-08 | Sorensen Benny (See Remarks) | Sale | 8,533 | 25.82 | 220,296 |
| 2021-06-08 | Sorensen Benny (See Remarks) | Option Ex | 8,533 | 3.29 | 28,073 |
| 2021-06-08 | Konstantinov Konstantin (Chief Technology Officer) | Sale | 7,276 | 25.79 | 187,618 |
| 2021-06-08 | Konstantinov Konstantin (Chief Technology Officer) | Option Ex | 7,276 | 3.29 | 23,938 |
| 2021-02-17 | Morrison Briggs (Director) | Buy | 4,761 | 21.00 | 99,981 |
| 2020-10-16 | Arch Venture Partners Viii, L.p. (10% Owner) | Buy | 235,000 | 15.00 | 3,525,000 |
| 2020-10-16 | Alaska Permanent Fund Corp | Buy | 235,000 | 15.00 | 3,525,000 |
| 2020-10-16 | Gillis Steven (Director) | Buy | 235,000 | 15.00 | 3,525,000 |
| 2020-10-16 | Afeyan Noubar (10% Owner) | Buy | 165,000 | 15.00 | 2,475,000 |
| 2020-10-13 | Melas Kyriazi Theo (Director) | Buy | 6,600 | 15.00 | 99,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CDAK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Codiak Biosciences, Inc. (symbol CDAK, CIK number 1659352) see the Securities and Exchange Commission (SEC) website.